You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Characteristics of subjects enrolled in the study

From: Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis

  TB Patients (n = 23) Healthy Controls (n = 21)
Median Age (range) 27 (22–66) 25 (20–33)
Male, n (%) 16 (59.3%) 13 (62.0%)
Presence of BCGa scars 15 (65.2%) 12 (57.1%)
PTBb diagnosis AFBc smear, positive 0 (0.0%) 0 (0.0%)
AFBc culture, positive 19 (82.6%) 0 (0.0%)
Cavity on Chest X-ray or CTd 8 (34.8%) 0 (0.0%)
Risk group for relapse High-risk 0 (0.0%) 0 (0.0%)
Moderate-risk 8 (34.8%) 0 (0.0%)
Low-risk 15 (65.2%) 0 (0.0%)
  1. aBCG Bacille Calmette-Guérin, b PTB Pulmonary tuberculosis, c AFB Acid-fast bacillus; d CT Computed tomography. Risk factors for relapse: i) the presence of a cavity lesion on chest X-ray or chest CT, and ii) the result of a positive sputum culture after 2 months of anti-TB treatment. The high-risk group was defined when patients had both risk factors i) and ii). The moderate-risk group was defined when patients had either risk factor i) or ii), and the low-risk group had neither risk factor